Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AMIX Autonomix Medical	$1.13 +1.8%	$1.39	$1.08 ▼ $21.49	$5.51M	-2.96	642,061 shs	184,842 shs
NUWE Nuwellis	$5.64 +2.5%	$10.41	$4.82 ▼ $175.98	$592K	N/A	417,017 shs	104,155 shs
TIVC Tivic Health Systems	$3.50 -0.3%	$3.84	$2.43 ▼ $15.64	$3.79M	1.98	767,938 shs	337,591 shs
VERO Venus Concept	$2.45 +0.4%	$2.52	$2.10 ▼ $14.50	$3.49M	0.12	1.06 million shs	9,802 shs

These 7 Stocks Will Be Magnificent in 2025

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AMIX Autonomix Medical	-2.63%	-11.90%	-22.38%	-41.58%	-91.36%
NUWE Nuwellis	+10.22%	+5.77%	-29.58%	-86.36%	-93.88%
TIVC Tivic Health Systems	-2.77%	+5.72%	-13.55%	-18.75%	-37.53%
VERO Venus Concept	-0.81%	-0.41%	-6.51%	+9.91%	-60.71%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
AMIX Autonomix Medical	3.165 of 5 stars	3.5	2.0	3.8	1.7	1.3
NUWE Nuwellis	1.4007 of 5 stars	0.0	4.0	1.7	1.7	1.3
TIVC Tivic Health Systems	0.5612 of 5 stars	0.0	3.0	2.7	0.0	0.6
VERO Venus Concept	1.391 of 5 stars	0.0	2.0	3.3	3.3	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AMIX Autonomix Medical	3.00	Buy	$16.50	1,360.18% Upside
NUWE Nuwellis	3.00	Buy	N/A	N/A
TIVC Tivic Health Systems	0.00	N/A	N/A	N/A
VERO Venus Concept	0.00	N/A	N/A	N/A

Current Analyst Ratings Breakdown

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AMIX Autonomix Medical	N/A	N/A	N/A	N/A	$3.29 per share	N/A
NUWE Nuwellis	$8.79M	0.07	N/A	N/A	$62.71 per share	0.09
TIVC Tivic Health Systems	$516K	7.35	N/A	N/A	$4.55 per share	0.77
VERO Venus Concept	$61.00M	0.06	N/A	N/A	$4.30 per share	0.57

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AMIX Autonomix Medical	-$11.41M	-$7.47	N/A	N/A	N/A	N/A	-174.70%	-133.35%	N/A
NUWE Nuwellis	-$11.16M	-$766.39	N/A	N/A	N/A	-112.09%	-655.31%	-141.83%	N/A
TIVC Tivic Health Systems	N/A	N/A	0.00	∞	N/A	-4.07%	-0.67%	-0.57%	8/14/2025 (Estimated)
VERO Venus Concept	-$47M	-$76.30	N/A	∞	N/A	-81.26%	-752.29%	-54.52%	8/14/2025 (Estimated)

Latest NUWE, AMIX, VERO, and TIVC Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/14/2025	Q2 2025	TIVC Tivic Health Systems	N/A	-$2.19	N/A	-$2.19	N/A	N/A
8/13/2025	Q1 2026	AMIX Autonomix Medical	N/A	-$1.07	N/A	-$1.07	N/A	N/A
8/12/2025	Q2 2025	NUWE Nuwellis	-$0.45	-$60.99	-$60.54	-$60.99	$2.20 million	N/A
5/29/2025	Q4 2025	AMIX Autonomix Medical	N/A	-$0.74	N/A	-$0.74	N/A	N/A
5/15/2025	Q1 2025	TIVC Tivic Health Systems	N/A	-$2.52	N/A	-$2.52	N/A	$0.07 million
5/15/2025	Q1 2025	VERO Venus Concept	-$14.08	-$17.44	-$3.36	-$17.44	$14.59 million	$13.64 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
AMIX Autonomix Medical	N/A	N/A	N/A	N/A	N/A
NUWE Nuwellis	N/A	N/A	N/A	N/A	N/A
TIVC Tivic Health Systems	N/A	N/A	N/A	N/A	N/A
VERO Venus Concept	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AMIX Autonomix Medical	N/A	5.63	5.63
NUWE Nuwellis	N/A	2.23	1.59
TIVC Tivic Health Systems	N/A	1.70	1.29
VERO Venus Concept	7.91	1.28	0.79

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AMIX Autonomix Medical	10.78%
NUWE Nuwellis	3.13%
TIVC Tivic Health Systems	4.25%
VERO Venus Concept	87.41%

Insider Ownership

Company	Insider Ownership
AMIX Autonomix Medical	32.40%
NUWE Nuwellis	20.08%
TIVC Tivic Health Systems	0.51%
VERO Venus Concept	28.04%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AMIX Autonomix Medical	1	4.88 million	3.30 million	N/A
NUWE Nuwellis	70	105,000	84,000	Not Optionable
TIVC Tivic Health Systems	10	1.08 million	1.08 million	Not Optionable
VERO Venus Concept	410	1.42 million	1.03 million	Not Optionable

NUWE, AMIX, VERO, and TIVC Headlines

Recent News About These Companies

Venus Concept Announces Second Quarter 2025 Financial Results

1 hour ago | globenewswire.com

Venus Concept to Release Second Quarter of Fiscal Year 2025 Financial Results on August 14, 2025

July 16, 2025 | globenewswire.com

Venus Concept Inc. to Release Q2 Fiscal 2025 Financial Results on August 14, 2025, with Conference Call Details

July 16, 2025 | quiverquant.comQ

VERO - Venus Concept Inc Financials - Morningstar

July 8, 2025 | morningstar.comM

Venus Concept Executes Debt-to-Equity Exchange Agreement

July 1, 2025 | tipranks.com

Venus Concept Announces $6.5 Million Debt-to-Equity Exchange Transaction

July 1, 2025 | globenewswire.com

Venus Concept Inc News (VERO) - Investing.com

June 26, 2025 | investing.com

Venus Concept Stock Climbs After Stock Offering Closes

June 9, 2025 | marketwatch.com

Venus Concept Inc. Closes Registered Direct Offering and Private Placement Raising Approximately $1.15 Million

June 9, 2025 | quiverquant.comQ

Venus Concept Announces Closing of Up To $3.45 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

June 9, 2025 | globenewswire.com

Venus Concept To Sell Hair Business To Meta Healthcare In $20M All-Cash Deal

June 8, 2025 | nasdaq.com

Venus Concept prices $3.45M in direct offering, warrants; shares up over 29%

June 7, 2025 | msn.com

Venus Concept Stock Is Soaring On Friday - Here's Why

June 7, 2025 | aol.comA

Venus Concept Sells Hair Business to Meta Healthcare

June 6, 2025 | tipranks.com

Venus Concept Stock Is Soaring On Friday - Here's Why

June 6, 2025 | benzinga.com

Venus Concept Inc.: Venus Concept Announces Definitive Agreement to Sell Venus Hair Business for $20 Million

June 6, 2025 | finanznachrichten.de

Venus Concept Shares Soar on Sale of Hair Business

June 6, 2025 | marketwatch.com

Venus Concept Announces Up To $3.45 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

June 6, 2025 | globenewswire.com

Venus Concept Inc. Sells Venus Hair Business to Meta Healthcare Group in $20 Million Deal

June 6, 2025 | quiverquant.comQ

Venus Concept to sell Venus Hair business for $20M, stock soars 50%

June 6, 2025 | msn.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

NUWE, AMIX, VERO, and TIVC Company Descriptions

Autonomix Medical NASDAQ:AMIX

$1.13 +0.02 (+1.80%)

Closing price 04:00 PM Eastern

Extended Trading

$1.12 -0.01 (-0.88%)

As of 04:16 PM Eastern

Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.

Nuwellis NASDAQ:NUWE

$5.64 +0.14 (+2.55%)

Closing price 04:00 PM Eastern

Extended Trading

$5.44 -0.19 (-3.46%)

As of 04:19 PM Eastern

Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors in Austria, Belarus, Brazil, Colombia, the Czech Republic, Germany, Greece, Hong Kong, India, Israel, Italy, Panama, Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.

Tivic Health Systems NASDAQ:TIVC

$3.50 -0.01 (-0.28%)

Closing price 03:59 PM Eastern

Extended Trading

$4.91 +1.41 (+40.26%)

As of 04:19 PM Eastern

Tivic Health Systems Inc. operates as a health tech company, focuses on developing and commercializing bioelectronic medicine. Its primary product is ClearUP, a bioelectronic medicine for the treatment of sinus and nasal inflammation. The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S. online retailers, such as BestBuy and FSAStore and through distributors. Tivic Health Systems, Inc. was incorporated in 2016 and is headquartered in Hayward, California.

Venus Concept NASDAQ:VERO

$2.45 +0.01 (+0.41%)

Closing price 04:00 PM Eastern

Extended Trading

$2.46 +0.00 (+0.20%)

As of 04:15 PM Eastern

Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin. The company also offers Venus Fiore, a device that delivers non-thermal RF with massage and magnetic field pulses to treat various medical conditions; Venus Bliss and Venus Bliss Max for non-invasive lipolysis of the abdomen, back, thights, and flanks in individuals with a body mass index of 30 or less; Venus Glow, a dermabrasion device used to improve skin appearance; and NeoGraft, an advanced hair restoration technology with an automated FUE and implantation system. In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae; ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles; and AI.ME an interactive, image-guided, and computer assisted system for fractional skin resurfacing. The company is headquartered in Toronto, Canada.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time